Ironwood Pharmaceuticals (IRWD) Debt to Equity: 2013-2025
Historic Debt to Equity for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Sep 2025 value amounting to -$2.21.
- Ironwood Pharmaceuticals' Debt to Equity fell 72.22% to -$2.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.34, marking a year-over-year decrease of 27.00%. This contributed to the annual value of -$1.28 for FY2024, which is 11.43% up from last year.
- According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Debt to Equity is -$2.21, which was down 16.69% from -$1.90 recorded in Q2 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' Debt to Equity peaked at $0.23 during Q1 2022, and registered a low of -$2.21 during Q3 2025.
- Moreover, its 3-year median value for Debt to Equity was -$1.44 (2024), whereas its average is -$1.54.
- Per our database at Business Quant, Ironwood Pharmaceuticals' Debt to Equity climbed by 23.53% in 2024 and then plummeted by 72.22% in 2025.
- Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Debt to Equity stood at $0.19 in 2021, then reached $0.23 in 2022, then reached -$1.44 in 2023, then increased by 11.43% to -$1.28 in 2024, then plummeted by 72.22% to -$2.21 in 2025.
- Its last three reported values are -$2.21 in Q3 2025, -$1.90 for Q2 2025, and -$1.15 during Q1 2025.